On this episode of Stock Movers: 

- Goldman Sachs Group Inc (GS) shares are up after the bank's stock traders posted the largest revenue haul in Wall Street history, as volatility sparked by the Trump administration’s trade war spurred a second straight record quarter for the unit. At $4.3 billion, equity-trading revenue for the second quarter was about $600 million more than what analysts were expecting and $100 million above the first-quarter total, according to a statement Wednesday. That also pushed profit above expectations for the period.

- ASML Holding NV (ASML) shares are sinking after Chief Executive Officer Christophe Fouquet walked back his forecast that sales will grow next year, blaming trade disputes and global tensions. Fouquet, who in October told investors he expected 2026 to be a growth year for the semiconductor industry and ASML, took a more cautious stance on Wednesday when the company reported its second-quarter results.

- Johnson & Johnson (JNJ) shares gained after the company beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as the pharmaceutical industry faces the dual threats of tariffs and a crackdown on drug pricing. J&J’s strong second quarter comes as President Donald Trump floats the idea of levies on the sector. On Tuesday night, he said tariffs on drugs could “probably” come at the end of the month, starting low and working their way up.

On this episode of Stock Movers:&nbsp; - Goldman Sachs Group Inc (GS) shares are up after the bank's stock traders posted the largest revenue haul in Wall Street history, as volatility sparked by the Trump administration&rsquo;s trade war spurred a second straight record quarter for the unit. At $4.3 billion, equity-trading revenue for the second quarter was about $600 million more than what analysts were expecting and $100 million above the first-quarter total, according to a statement Wednesday. That also pushed profit above expectations for the period. - ASML Holding NV (ASML) shares are sinking after Chief Executive Officer Christophe Fouquet walked back his forecast that sales will grow next year, blaming trade disputes and global tensions. Fouquet, who in October told investors he expected 2026 to be a growth year for the semiconductor industry and ASML, took a more cautious stance on Wednesday when the company reported its second-quarter results. - Johnson &amp; Johnson (JNJ) shares gained after the company beat Wall Street&rsquo;s quarterly sales expectations and raised its full-year outlook, a show of confidence as the pharmaceutical industry faces the dual threats of tariffs and a crackdown on drug pricing. J&amp;J&rsquo;s strong second quarter comes as President Donald Trump floats the idea of levies on the sector. On Tuesday night, he said tariffs on drugs could &ldquo;probably&rdquo; come at the end of the month, starting low and working their way up.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Goldman Sachs Profit Surges, ASML Growth Outlook Cools, J&J Beats

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/251d9290-3bce-4579-9bf9-b31c013e01be/transcript

Advertisement